EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC 4.0

Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services

Mark Drayson iD, Tom Jennis, Ira Laketic-Ljubojevic, Dina Patel, Guy Pratt iD, Suzanne Renwick, Alex Richter, Rachel Wheeler, Joanna Sheldon, Ross Sadler, Mary Stapleton, Fenella Willis und 2 weitere

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19224 ↗

Kurz gefasst

Leitlinie in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Mark Drayson und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Immunology Service, University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Multiple Myeloma, Hematology. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Cancer Research UK, Myeloma UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment advances have greatly improved survival, but myeloma is among the worst of all cancers for delayed diagnosis, causing serious morbidities and early deaths. This delay is largely because the symptom profile of myeloma has very low specificity, and in primary care, myeloma is rare. However, initiating the journey to diagnosis simply requires considering myeloma and sending blood to test for monoclonal immunoglobulin. Laboratory tests reliably detect monoclonal immunoglobulin, which is present in 99% of myeloma cases, so why do health care systems have such a problem with delayed diagnosis? The Myeloma UK early diagnosis programme has brought together diverse expertise to investigate this problem, and this article was prepared by the programme's working group for laboratory best practice. It reviews evidence for test requesting, analysis and reporting, for which there is large variation in practice across the United Kingdom. It presents a ‘GP Myeloma diagnostic tool’ and how it can be integrated into laboratory practice alongside a laboratory best practice tool. It proposes improved requesting and integration with haematology services for reporting and interpretation. Here the laboratory has a central role in creating efficient and cost‐effective pathways for appropriate and timely bone marrow examination for myeloma diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaHematologyHumansEarly Detection of CancerUnited KingdomPrimary Health Care

Stichwörter der Autor:innen

earlier diagnosislaboratory practicemyeloma

Autor:innen und Institutionen

  • Clinical Immunology Service, University of Birmingham, Birmingham, UK.
  • Myeloma UK, Edinburgh, UK.
  • UK NEQAS Immunology, Immunochemistry & Allergy, Sheffield Teaching Hospitals, Sheffield, UK.
  • Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Protein Reference Unit, South West London Pathology, St Georges Hospital, London, UK.
  • Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

ORCID-Profile: Mark Drayson, Guy Pratt

Förderung

  • Cancer Research UK
  • Myeloma UK

Zitieren

APA

Drayson, M., Jennis, T., Laketic-Ljubojevic, I., Patel, D., Pratt, G., Renwick, S., Richter, A., Wheeler, R., Sheldon, J., Sadler, R., Stapleton, M., Willis, F., Whiston, M., & for Myeloma UK working group for laboratory best practice (2024). Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services. British Journal of Haematology. https://doi.org/10.1111/bjh.19224

Vancouver

Drayson M, Jennis T, Laketic-Ljubojevic I, Patel D, Pratt G, Renwick S, et al. Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services. British Journal of Haematology. 2024. doi:10.1111/bjh.19224

BibTeX
@article{Drayson2024,
  author = {Drayson, Mark and Jennis, Tom and Laketic-Ljubojevic, Ira and Patel, Dina and Pratt, Guy and Renwick, Suzanne and Richter, Alex and Wheeler, Rachel and Sheldon, Joanna and Sadler, Ross and Stapleton, Mary and Willis, Fenella and Whiston, Mairi and for Myeloma UK working group for laboratory best practice, for Myeloma UK working group for laboratory best practice},
  title = {Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19224}
}
Kostenlos starten →